![]() |
![]() |
![]() |
||
July 29, 2008 |
|
|||
![]() |
Dear Shareholder, Throughout the summer, EnWave has been working with the German Investor Relations firm AXINO AG to develop a five-step European communications program with the goal of increasing share trading activity for ENW. Starting with today's release of a German-language website, the two companies will now focus on the dissemination of background materials to the AXINO investor group in order to introduce the EnWave “story” to investors abroad.
The summer is always a difficult time for investors due to low trading volume and holiday schedules, but this summer has been particularly challenging in the capital markets. Enwave has been working diligently to advance our testing programs for both bioREV and nutraREV, and the Company is scheduled to deliver results for both of these technologies by the latter part of this year. With these results in hand, we will be aggressively pursuing new customers and expanding our investor relations activities to help stimulate trading activity and attract new investors to EnWave. Please feel free to contact me with your questions about the company at 604-603-6549 or by e-mail at jthompson@enwave.net. Kind regards,
> EnWave Homepage |
|
||
|
||||
![]() |
![]() |
![]() |